MRF-Logo2019-Horizontal-RGB
IDO Inhibitor
REGISTER
The information on this site is not intended or implied to be a substitute for professional medical advice, diagnosis or treatment. Content within the patient forum is user-generated and has not been reviewed by medical professionals. Other sections of the Melanoma Research Foundation website include information that has been reviewed by medical professionals as appropriate. All medical decisions should be made in consultation with your doctor or other qualified medical professional.

IDO Inhibitor

› Forums › General Melanoma Community › IDO Inhibitor

  • Post
    • February 24, 2015 at 1:59 pm
    G-Samsa
    Participant

      Read this morning that BMS has just purchased Flexus' IDO inhibitor assets.  This is likely good news. (I think, hope). Back before anti-PD1 took center stage, early IDO trials were showing great promise. (I remember someone on this site indicating a 48 percent response rate for a trial at the Angeles Clinic) I believe IDO interferes with a whole other pathway than the PD1/PDL1 route, and may therefore offer another complimentary way to tackle the beast.   There is indication that BMS intends to initiate some clinical trials within six months… It's nice to have a heavyweight picking this up–I suppose that's a benefit of the crowded PD1 field.

       

       

    Viewing 5 reply threads
    • Replies
    Viewing 5 reply threads
    • You must be logged in to reply to this topic.
    About the MRF Patient Forum

    The MRF Patient Forum is the oldest and largest online community of people affected by melanoma. It is designed to provide peer support and information to caregivers, patients, family and friends. There is no better place to discuss different parts of your journey with this cancer and find the friends and support resources to make that journey more bearable.

    The information on the forum is open and accessible to everyone. To add a new topic or to post a reply, you must be a registered user. Please note that you will be able to post both topics and replies anonymously even though you are logged in. All posts must abide by MRF posting policies.